Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence
Staphylococcal bacteremia and enterococcal bacteremia are prevalent in hospitalized or recently instrumented patients, and are associated with significant morbidity and mortality. They are often difficult to treat due to the pathogenicity of the organisms, poor response to antibiotics, and increasin...
Main Authors: | Rachel Bartash, Priya Nori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971217301984 |
Similar Items
-
In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
by: Siheng Wang, et al.
Published: (2021-08-01) -
Vancomycin Resistance in <i>Enterococcus</i> and <i>Staphylococcus aureus</i>
by: Gen Li, et al.
Published: (2022-12-01) -
A New Kind of Quinonic-Antibiotic Useful Against Multidrug-Resistant S. aureus and E. faecium Infections
by: Javier Campanini-Salinas, et al.
Published: (2018-07-01) -
Emergence of vancomycin-resistant Enterococcus faecium after use of inhaled vancomycin in a cystic fibrosis patient chronically infected with methicillin-resistant Staphylococcus aureus
by: Luiz Vicente Ribeiro Ferreira da Silva Filho, et al.
Published: (2008-09-01) -
Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
by: Hayato Mitaka, et al.
Published: (2019-08-01)